Health
A new study suggests that psychedelics may have the ability to unlock limited time spans of learning called “critical periods,” which are the only chance to learn certain behaviors.
Psychedelic users are skeptical of information from governments and pharma companies, consider popular media inaccurate, but learn from their own experiences and from friends.
A team of researchers in Brazil is investigating ayahuasca as a possible therapeutic treatment for depression and determining the impact of the psychedelic effect.
The owner of the state’s first psilocybin service center to receive a license speaks about the lengthy path to approval.
The scientist whose pivotal studies set in motion a renaissance in psychedelic research, points the way forward while reflecting on his own mortality.
Psychedelics are safe for healthy older adults, a new review of clinical trials suggests, but few are included in research studies.
The treatment, developed by Awakn Life Science, was administered today in New York City at the Nushama ketamine clinic.
The Oregon Health Authority has released the final version of rules that will apply to all aspects of psilocybin treatment in Oregon, which became legal on January 1.
A jury in Monterey California has returned a verdict that found MAPS liable in a wrongful death lawsuit.
After a three-week trial, a jury found MAPS partially responsible for the wrongful death of a woman cared for in the Zendo Project peer support space and liable for damages.
